US2016030212A1PendingUtilityA1

Rubber toughened bioresorbable polymer peripheral scaffolds

Assignee: ABBOTT CARDIOVASCULAR SYSTEMSPriority: Oct 3, 2011Filed: Oct 12, 2015Published: Feb 4, 2016
Est. expiryOct 3, 2031(~5.2 yrs left)· nominal 20-yr term from priority
A61L 31/141A61F 2230/0013A61L 31/041A61F 2210/0057A61F 2/915A61L 31/129A61F 2230/0054A61F 2210/0004A61L 31/148
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Bioabsorbable scaffolds are disclosed with a rigid polymer component and a rubbery polymer component. The rubbery polymer component is miscible, partially miscible, or immiscible with the rigid polymer component.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . A stent comprising a scaffold made from a blend of a matrix polymer and a random copolymer of a rubbery polymer component and a rigid polymer component,
 wherein the rubbery polymer component is selected from the group consisting of poly(4-hydroxy butyrate), polycaprolactone, polybutylene succinate, and polydioxanone,   wherein the rigid polymer component and the matrix polymer comprise poly(L-lactide) (PLLA),   wherein the rubbery polymer component is 1 to 15 wt % of the scaffold,   wherein the rubbery polymer component is 20 and 80 mol % of the copolymer,   wherein the scaffold comprises a plurality of rings with each of the rings having ring struts interconnected at hinge portions, such that the ring struts and the hinge portions form a unitary ring and the scaffold is configured for being plastically deformed when crimped to a balloon having a nominal inflation diameter, the scaffold having an expanded diameter when plastically deformed from a crimped state by the balloon inflated to the nominal inflation diameter, and the hinge portions are plastically deformed when the scaffold is crimped to the balloon and when the scaffold is expanded by the balloon.   
     
     
         3 . The stent of  claim 2 , wherein the number average molecular weight (Mn) of the copolymer is 30 to 500 kDa and is less than an Mn of the matrix polymer. 
     
     
         4 . The stent of  claim 2 , wherein the copolymer is poly(L-lactide-co-ε-caprolactone). 
     
     
         5 . The stent of  claim 2 , wherein the rubbery polymer component forms a dispersed phase with domains distributed throughout a matrix phase composed of the matrix polymer. 
     
     
         6 . The stent of  claim 2 , wherein the scaffold attains greater than 80% of its expanded diameter after being crushed to at least 50% of its expanded diameter.

Join the waitlist — get patent alerts

Track US2016030212A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.